In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lilly enlists Innovex to help launch Cymbalta

Executive Summary

Innovex, the contract drug commercialization unit of CRO Quintiles Transnational, will supply and pay for more than 500 sales reps to help Lilly with the US launch of its Cymbalta (duloxetine HCl), an antidepressant currently under review for FDA approval.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • Includes Royalty or Profit Split Information
    • Marketing (Licensing)

Related Companies